12:00 AM
 | 
May 10, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Remicade infliximab: Marketed

CNTO published in The New England Journal of Medicine previously reported results of its 94-patient Phase...

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >